Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)
CUSIP: 92337R101
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Class A Common Stock, par value $0.001 per share
- Shares outstanding
- 72,325,000
- Total 13F shares
- 65,067,827
- Share change
- +801,757
- Total reported value
- $1,890,768,857
- Put/Call ratio
- 207%
- Price per share
- $29.06
- Number of holders
- 173
- Value change
- +$37,111,876
- Number of buys
- 99
- Number of sells
- 80
Quarterly Holders Quick Answers
What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92337R101:
Top shareholders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
13D/G
|
Company |
8.9%
from 13D/G
|
6,300,000
|
$148,428,000 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.2%
|
4,479,717
|
$105,543,000 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
5.8%
|
4,165,540
|
$98,140,122 | — | 30 Jun 2025 | |
| Kynam Capital Management, LP |
13D/G
13F
|
Company |
5.4%
|
3,426,887
|
$83,444,698 | $0 | 30 Jun 2025 | |
| Commodore Capital LP |
3/4/5
13F
|
10%+ Owner · Company |
1.1%
from 13F
|
4,400,000
|
$79,200,000 | — | 10 Jan 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
4.6%
|
3,348,117
|
$78,881,637 | — | 30 Jun 2025 | |
| James E. Flynn |
13D/G
|
Deerfield Mgmt, L.P. |
5.2%
|
3,348,117
|
$75,299,151 | $0 | 06 Jun 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
4.3%
|
3,100,000
|
$73,036,000 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
3,001,108
|
$70,706,104 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
4%
|
2,909,964
|
$68,558,751 | — | 30 Jun 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
3.9%
|
2,793,987
|
$65,826,334 | — | 30 Jun 2025 | |
| Sofinnova Venture Partners X, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,467,156
|
$62,408,808 | — | 06 Feb 2023 | |
| Woodline Partners LP |
13F
|
Company |
3.6%
|
2,608,372
|
$61,453,244 | — | 30 Jun 2025 | |
| Eversept Partners, LP |
13F
|
Company |
3.3%
|
2,383,055
|
$56,144,776 | — | 30 Jun 2025 | |
| Emster Kurt von |
3/4/5
|
Director |
—
mixed-class rows
|
2,987,984
mixed-class rows
|
$53,605,062 | — | 17 May 2021 | |
| Abingworth LLP |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
2,970,156
mixed-class rows
|
$53,284,158 | — | 13 May 2021 | |
| Carlyle Group Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,960,231
|
$53,284,158 | — | 17 Aug 2022 | |
| MORGAN STANLEY |
13F
|
Company |
3.1%
|
2,238,252
|
$52,733,229 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.8%
|
2,017,683
|
$47,536,611 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.9%
|
1,350,000
|
$31,806,000 | — | 30 Jun 2025 | |
| Longitude Capital Partners IV, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,714,285
|
$30,857,130 | — | 06 Feb 2023 | |
| Longitude Prime Partners, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,714,285
|
$30,857,130 | — | 06 Feb 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
1,294,958
|
$30,513,273 | — | 30 Jun 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
1.6%
|
1,150,000
|
$27,094,000 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.1%
|
772,814
|
$18,207,498 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.99%
|
714,428
|
$16,831,966 | — | 30 Jun 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.85%
|
617,396
|
$14,545,850 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.84%
|
605,013
|
$14,254,106 | — | 30 Jun 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
0.78%
|
563,075
|
$13,266,047 | — | 30 Jun 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.78%
|
562,981
|
$13,263,832 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.78%
|
562,866
|
$13,261,123 | — | 30 Jun 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.75%
|
545,000
|
$12,840,200 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.7%
|
504,621
|
$11,888,871 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.64%
|
460,510
|
$10,849,616 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.61%
|
444,456
|
$10,471,383 | — | 30 Jun 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.59%
|
427,939
|
$10,082,243 | — | 30 Jun 2025 | |
| Tri Locum Partners LP |
13F
|
Company |
0.57%
|
413,114
|
$9,732,966 | — | 30 Jun 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.56%
|
401,427
|
$9,457,620 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.55%
|
394,280
|
$9,289,237 | — | 30 Jun 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.52%
|
372,749
|
$8,781,966 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.43%
|
311,942
|
$7,349,354 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.43%
|
310,547
|
$7,316,488 | — | 30 Jun 2025 | |
| First Turn Management, LLC |
13F
|
Company |
0.43%
|
309,666
|
$7,295,731 | — | 30 Jun 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.41%
|
298,976
|
$7,043,875 | — | 30 Jun 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.41%
|
296,941
|
$6,996,228 | — | 30 Jun 2025 | |
| Beth C. Seidenberg |
3/4/5
|
Director |
—
mixed-class rows
|
149,565
mixed-class rows
|
$6,715,972 | — | 14 May 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.35%
|
254,153
|
$5,988,000 | — | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.34%
|
247,216
|
$5,824,409 | — | 30 Jun 2025 | |
| Alphabet Inc. |
13F
|
Company |
0.33%
|
241,264
|
$5,684,180 | — | 30 Jun 2025 | |
| AXA S.A. |
13F
|
Company |
0.32%
|
228,951
|
$5,394,086 | — | 30 Jun 2025 |
Institutional Holders of Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) as of Q3 2025
As of 30 Sep 2025,
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) was held by
173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,067,827 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, BlackRock, Inc., Kynam Capital Management, LP, PRICE T ROWE ASSOCIATES INC /MD/, DEERFIELD MANAGEMENT COMPANY, L.P., VANGUARD GROUP INC, FMR LLC, Eversept Partners, LP, Sofinnova Investments, Inc., and STATE STREET CORP.
This page lists
173
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
171
Q3 2025 holders
173
Holder diff
2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.